Serum DPP4 activity was assessed in a total of 184 individuals, including 102 hospitalized patients with COVID-19, 43 post-COVID-19 plasma donors and 39 individuals who were never exposed to SARS-CoV-2 (with sampling prior to the pandemic). Here, DPP4 is linked to COVID-19.